Search For "remdesivir"
COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): While the Central government has indicated drugs like Remdesivir and Tocilizumab as an "investigational therapies" for the treatment of hospitalized coronavirus patient, the Union health ministry has alarmed all states, union territories and medical college
Read More
No shortage of COVID-19 medicine in Goa, every patient treated as VIP: Ran
Updated : 5 years, 8 months ago IST
Panaji (Goa) [India], July 11 (ANI): Goa Health Minister Vishwajit Rane on Friday said that the state has sufficient medicines to fight coronavirus and every patient is treated like a VIP.
Read More
Strict action will be taken against black marketeers of Remdesivir: Anil D
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 10 (ANI): Maharashtra Home Minister Anil Deshmukh on Friday said that strict action will be taken against those involved in black marketing of Remdesivir and other medicine which are useful to treat COVID-19 patients.
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
COVID19: Top drug regulator directs states drug controller to be vigilant
Updated : 5 years, 8 months ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Health ministry revises remdesivir dosage for COVID-19 patients
Updated : 5 years, 8 months ago IST
New Delhi [India], July 4 (ANI): The Union Health Ministry on Friday has revised the dosage of the antiviral drug--remdesivir, being administered to hospitalized COVID-19 patients from the earlier six-days to five-day treatment course.
Read More
DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted eme
Updated : 5 years, 8 months ago IST
New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on Thursday.
Read More
COVID-19: States being delivered generic version of Remdesivir, 20 thousan
Updated : 5 years, 8 months ago IST
New Delhi [India], June 25 (ANI): Domestic pharma giant Hetero has started delivering the generic version of 20,000 vials of Covifor (Remdesivir) across the country. The product is priced at Rs 5,400/- per vial.
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 8 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 8 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More